drugset / Trial / NCT00671255
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This purpose of this study is to evaluate the safety and effectiveness of Ramelteon, once daily (QD), in elderly participants with chronic insomnia.
Timeline
- Start
- 2002-12
- Primary completion
- 2004-01
- Completion
- 2004-01
Publications
- Results Mini LJ, Wang-Weigand S, Zhang J. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. Am J Geriatr Pharmacother. 2007 Sep;5(3):177-84. doi: 10.1016/j.amjopharm.2007.09.004.
- Results Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med. 2006 Jun;7(4):312-8. doi: 10.1016/j.sleep.2006.01.003. Epub 2006 May 18.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 4 mg | Oral |
| Subject | Ramelteon | Unknown | 8 mg | Oral |